Papers
19
Total Citations
163
H-Index
6
About
Fumitaka Koga is a pioneering urologic surgeon whose research focuses on advancing minimally invasive surgical techniques for urologic cancers, particularly prostate and renal cell carcinoma. His most impactful work includes the development of the TMDU-S-3D system, a novel three-dimensional head-mounted display for gasless single-port radical nephrectomy, which has garnered 63 citations for its innovative approach to enhancing surgical visualization. Dr. Koga leads the MSUG94 Group, a large multicenter consortium in Japan, through which he has made substantial contributions to understanding robot-assisted radical prostatectomy (RARP) outcomes. His studies, with citations ranging from 4 to 15, have clarified the limited benefit of pelvic lymphadenectomy for biochemical recurrence, identified prognostic factors such as lymphovascular invasion and positive surgical margin locations, and developed nomograms for predicting lymph node involvement. Notably, his work on hospital volume’s impact on RARP outcomes and risk factors for inguinal hernia post-surgery provides critical insights for optimizing patient care. With over 140 total citations across his top papers, Dr. Koga’s research bridges technological innovation and evidence-based practice, offering valuable guidance for surgeons and researchers seeking to improve oncological and perioperative outcomes in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4Development of Outdoor Service Robots13 citations · 2006
- 5
- 6
- 7
- 8
- 9
- 10